Fibrin Sealants Market Size, Share & Industry Analysis, By Type (Liquid, and Patches) By Application (Orthopedic Surgery, Cardiovascular surgery, General Surgery, Transplant Surgery, and Others) By End User (Hospitals, Specialty Clinics, and Others) and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

                                          
We have updated Fibrin Sealants Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Fibrin Sealants market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Fibrin Sealants market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Fibrin Sealants Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Fibrin Sealants Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Fibrin Sealants Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Baxter Projected to Dominate the Global Market
The fibrin sealants market is a consolidated market as a limited number of players hold majority of the market share. As of 2018, Baxter and Ethicon (part of Johnson & Johnson Services, Inc.) held majority of the market share in this market, with Baxter leading in terms of revenue. This is mainly due to strong brand presence, consolidated customer base, presence across all regions, and a robust distribution channel. The market share of Ethicon is anticipated to increase over the forecast period due to continuous product introductions, strategic partnerships, and focus on penetration in emerging markets.

List Of Key Companies Covered:

  
Baxter
  
CSL Limited
  
Takeda Pharmaceutical Company Limited
  
Johnson & Johnson Services, Inc.,
  
Stryker
  
Vivostat A/S.
  
Others

REPORT COVERAGE

The fibrin sealants market report presents a comprehensive assessment of the global market by offering valuable insights, facts, industry-related information, and historical data. Several methodologies and approaches are adopted to make meaningful assumptions and views. Furthermore, the report offers a detailed analysis and information as per the market segments, helping our readers to get a comprehensive overview of the market.

Along with this, the report provides an elaborative analysis of the fibrin sealants market dynamics and competitive landscape. Various key insights presented in the report are the technological advancements in this market, new product launches by key players, key industry developments: mergers, acquisitions & partnerships, regulatory scenarios, and trends of usage of fibrin sealants, prevalence of major surgical procedures for key countries.

REPORT SCOPE & SEGMENTATION

 SEGMENTATION

By Type

  
Liquid
  
Patches

By Application

  
Orthopedic Surgery
  
Cardiovascular surgery
  
General Surgery
  
Transplant Surgery
  
Others

By End User

  
Hospitals
  
Specialty Clinics
  
Others

By Region

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia-Pacific (Japan, China, India, Australia, and Rest of Asia-Pacific)
  
Rest of the World

INDUSTRY DEVELOPMENTS:

In April 2017, Baxter unveiled design enhancements to Tisseel fibrin sealant hemostatic agents at AORN meeting.

In November 2018, Baxter introduced new Tisseel prima syringe at 2018 American Association of Gynecologic Laparoscopists meeting. Baxter also unveiled its new Tisseel 40cm Duplotip Rigid Applicator, an extended length applicator that is helpful when surgeons need to apply Tisseel to hard-to-reach areas laparoscopically.

In May 2019, J&J s Ethicon Acquired Takeda"s TachoSil Surgical Patch for $400M.